MarketInOut Stock Screener Log In | Sign Up
 

Vericel Corp

NASDAQ • Healthcare • Biotechnology • Quote as of 09/11/2026
Vericel Corp stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,963.26 mln
Float39.76 mln
Earnings Date11/11/2026

EPS

0.48
Overpriced

P / E

79.88
Speculative

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.69
Likely reliable

1-Year Forecast

60.57
Exceptional upside

Relative Strength

21 / 100
Significantly lagging

Business Description

Vericel Corporation, based in Cambridge, Massachusetts, develops and sells specialized medical treatments using living cells and biological materials. The company offers three main products: a knee cartilage repair treatment, a permanent skin replacement for severe burn patients, and a burn wound cleaning therapy used in both adults and children. Originally founded in 1989 under the name Aastrom Biosciences, Vericel serves healthcare providers across North America in the fields of sports medicine and burn care.

Key Fundamentals

EPS0.48
P/E79.88
ROE7.08
RPS6.04
ROIC5.92
ROA5.12
Interest Cover28.49
EBITDA, mln31.75
EV / EBITDA63.86
EV / EBIT78.83
Revenue, mln306
EV / Revenue6.62

Financial Strength

Altman Z-Score9.7
Piotroski F-Score 8 / 9
Beneish M-Score-2.69
Price to Intrinsic Value4.24
Price to Graham Number4.72
1-Year Target Price60.57
Short Ratio9.89
Short % of Float11.97

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.26% 19 / 100   
1 Month -14.29% 14 / 100   
2 Months 7.43% 80 / 100   
6 Months 19.4% 78 / 100   
1 Year 22.45% 75 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us